Technology

Catalent commits to ADCs by upping its stake in Redwood

News from Interphex 2014

Catalent commits to ADCs by upping its stake in Redwood

By Dan Stanton

Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.

EMD Millipore talks single use technology at Interphex 2011

EMD Millipore talks single use technology at Interphex 2011

By Gareth Macdonald

How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.